Online learning: LATEST FRONTIERS IN ANTICOAGULATION THERAPY
Featuring Dr. John Eikelboom: Key Questions for 2018 Clinical Practice AddressedJan. 12, 2018
Welcome to the online session focused on the latest developments in anticoagulation treatment.
During this Expert Session, held on january 12, 2018, dr. John Eikelboom, McMaster University in Hamilton, Ontario, Canada, together with an international expert panel, provided an overview of latest scientific and clinical advances in anticoagulation therapy and commented on different issues in different countries.
Educational Objectives were:
- To review and summarize recent clinical evidence on non-vitamin K antagonist anticoagulants (NOACS) in patients with atrial fibrillation and trombosis
- To provide clinical guidance, based on novel insights on safety and tolerability, on management of patients in challenging situations
- To provide an expert perspective on the appropriate use of NOACs in clinical practice
- Prof. Dr. Saskia Middeldorp,Chair/Moderator - Academic Medical Center Amsterdam, The Netherlands
- Dr Hanna Pohjantahti-Maaroos, Moderator - Kuopio University Hospital, Finland
- Prof. dr. John Eikelboom, Speaker - McMaster University, Ontario, Canada
- Lecture 1 - Anticoagulation 2017: The key lessons and implications from recent clinical trials
- Lecture 2 - Practical guidance on NOACs and safety: How to deal in challenging situations in AF
- Lecture 3 - Appropriate use of NOACs: What is state of the art for 2018?
The programme was funded funded by an educational grant from Boehringer-Ingelheim